{
    "organizations": [],
    "uuid": "d838c8835516c4910e2d93512e4f3bf4cbcc0cd8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jiangsu-nhwa-pharmaceutical-and-un/brief-jiangsu-nhwa-pharmaceutical-and-unit-pass-review-of-high-tech-enterprise-recognition-idUSL4N1RI2KF",
    "ord_in_thread": 0,
    "title": "BRIEF-Jiangsu Nhwa Pharmaceutical and unit pass review of high-tech enterprise recognition",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5(Reuters) - Jiangsu Nhwa Pharmaceutical Co Ltd\n* Says co and coâ€™s Jiangsu-based pharmaceutical unit passed the review of high-tech enterprise recognition and could enjoy tax preference of 15 percent for three years (2017 to 2019)\nSource text in Chinese: goo.gl/Gpu1wq ; goo.gl/p7JUKm\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-05T15:12:00.000+03:00",
    "crawled": "2018-04-06T22:09:28.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "jiangsu",
        "nhwa",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "co",
        "co",
        "pharmaceutical",
        "unit",
        "passed",
        "review",
        "enterprise",
        "recognition",
        "could",
        "enjoy",
        "tax",
        "preference",
        "percent",
        "three",
        "year",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}